StonvexLoading…
StonvexStonvexStonvexCore line items from KDK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.83M | $3.80M | $2.74M | $1.47M |
Operating Income | $-37.85M | $-112.63M | $-73.92M | $-18.60M |
Net Income | $26.49M | $-585.52M | $-511.85M | $-128.19M |
EPS (Diluted) | $0.10 | $-6.42 | $-8.13 | $-2.16 |
Total Assets | $130.82M | $159.41M | $177.84M | $557.25M |
Total Liabilities | $153.55M | $219.27M | $174.16M | $25.59M |
Cash & Equivalents | $64.95M | $50.76M | $146.20M | $17.67M |
Free Cash Flow OCF − CapEx | $-35.02M | $-116.47M | $-82.10M | $-18.83M |
Shares Outstanding | 177.48M | 175.44M | 174.96M | 59.26M |